Exari Licenses/Coupa
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Food and Drug Administration is forecasting the procurement of Exari licenses and Coupa platform support to facilitate the development, maintenance, and management of critical communication templates used in regulatory review processes, including approval letters and complete response letters. This initiative aims to streamline workflow efficiency and ensure consistency in documentation across FDA’s Center for Drug Evaluation and Research. The effort is classified under NAICS code 541519, indicating it relates to other computer-related services, and is intended to enhance operational capabilities through automated document generation and contract lifecycle management tools. No set-aside provisions have been identified, and the procurement remains open to all qualified vendors. The point of contact for program inquiries is the Cder Acquisition Liaison, with the contracting officer position yet to be filled. The forecast was posted on May 25, 2026, and is accessible through the HHS OSDBU procurement portal.
General Info
Agency
NAICS
Place of Performance
USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
